Ascendis Pharma A/S (ASND) vs peers

$253.00

Latest weekly close · Market cap $16.6B

ASND's P/E is 19.4x, compared with 30.0x at the middle of 4 peers.

Peer group: Biotechnology. Updated Oct 30, 2026.

ASND and Biotechnology, ranked by P/E
Stock	P/E	Own 5-year percentile
ASNDAscendis Pharma A/S	19.4×	n/m, not ranked
ABBVAbbVie	82.1×	77
VRTXVertex Pharmaceuticals	31.5×	89
AMGNAmgen	28.6×	80
REGNRegeneron Pharmaceuticals	20.2×	68
GILDGilead Sciences	n/m	n/m, not ranked
MRNAModerna	n/m	n/m, not ranked
NTRANatera Inc	n/m	n/m, not ranked
RVMDRevolution Medicines Inc	n/m	n/m, not ranked
Peer median	30.0×

How to read this comparison

Up to eight covered companies in the same industry, largest market value first.

P/E divides the share price by earnings per share over the last twelve months. The peer median leaves out ASND and stocks without a reading.

Each percentile compares a stock with its own weekly readings over the last five years, so 20 means its P/E is above 20% of its own past readings. It needs at least 26 weeks of history. It is not a rank against the other stocks in this table.

Different growth rates, margins and financial risks can explain different multiples. Stocks without positive earnings have no reading.

ASND versus the peer median

-35%

ASND: 19.4×
Peer median: 30.0×
Own 5-year median: n/m

ASND P/E history Calculate ASND's implied price